CYP2E1 and tuberculosis: In order to draw a more precise conclusion and support the use of GSTT1 as an additional genetic biomarker for predicting the risk of ATDILI in TB patients, further studies are warranted to investigate multi-genetic effects including NAT2, CYP2E1, and GSTs genetic polymorphisms on the risk of ATDILI.